Advertisement
Screener

ELOXX PHARMACEUTICALS, INC. (ELOX) Debt / Equity

ELOXX PHARMACEUTICALS, INC. (ELOX) Debt / Equity

  • 2025-12-31: Debt/Equity Ratio -0.08.
  • 2024-12-31: Debt/Equity Ratio -0.27.
  • 2023-12-31: Debt/Equity Ratio -0.17.
  • 2023-09-30: Debt/Equity Ratio -0.27.

Complete source-backed debt/equity ratio history.

Available history
2019-03-31 to 2025-12-31
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2025-12-31-0.08
2024-12-31-0.27
2023-12-31-0.17
2023-09-30-0.27
2023-06-30-0.3
2023-03-310.34
2022-12-31-1.18
2022-09-30-2.49
2022-06-306.76
2021-12-310.54
2021-06-300.23
2021-03-313.81
2020-12-311.14
2020-09-300.84
2020-06-300.68
2020-03-310.54
2019-12-310.41
2019-09-300.32
2019-06-300.26
2019-03-310.42

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2025-12-31-0.08
2024-12-31-0.27
2023-12-31-0.17
2022-12-31-1.18
2021-12-310.54
2020-12-311.14
2019-12-310.41

Similar stocks

Stock NameCountryMarket CapPE Ratio
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
BioStem Technologies, Inc. (BSEM)United States$0.069B
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
EXOZYMES INC. (EXOZ)United States$0.058B
BioAtla, Inc. (BCAB)United States$0.058B-0.21
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
Vaxart, Inc. (VXRT)United States$0.080B3.84
Tevogen Inc. (TVGN)United States$0.049B